SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-18-059455
Filing Date
2018-02-27
Accepted
2018-02-27 08:14:56
Documents
2
Period of Report
2018-02-27
Items
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K d549014d8k.htm 8-K 14534
2 EX-99.1 d549014dex991.htm EX-99.1 11168
  Complete submission text file 0001193125-18-059455.txt   27005
Mailing Address 131 HARTWELL AVENUE SUITE 320 LEXINGTON MA 02421
Business Address 131 HARTWELL AVENUE SUITE 320 LEXINGTON MA 02421 781-761-4904
Aldeyra Therapeutics, Inc. (Filer) CIK: 0001341235 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36332 | Film No.: 18642989
SIC: 2834 Pharmaceutical Preparations